Urine D-arabinitol/L-arabinitol ratio in diagnosing Candida infection in patients with haematological malignancy and HIV infection


Autoria(s): Eisen, Damon P.; Bartley, Paul B.; Hope, William; Sigmundsdottir, Gudrun; Pehrson, Christina; Larsson, Lennart; Christensson, Bertil
Contribuinte(s)

R. N. Jones

S. M. Lipson

et al.

Data(s)

01/01/2002

Resumo

Adult patients with hematologic malignancies along with HIV infected patients were prospectively studied to determine the performance of urine D-arabinitol/L-arabinitol (DA/LA) ratio in diagnosing invasive candidiasis. Ten evaluable febrile neutropenic patients had proven invasive candidiasis and elevated DA/LA ratios were found in 5. Invasive candidiasis with normal DA/LA ratios was most frequently due to Candida krusei infection. This Candida species is a non-producer of arabinitol. Only 4 of 81 febrile neutropenic patients given either antifungal prophylaxis or empiric antifungal treatment had elevated DA/LA ratios. Only 1 of 15 HIV positive patients with either oropharyngeal or esophageal candidiasis had elevated DA/LA ratios. Widespread use of fluconazole prophylaxis in bone marrow transplantation patients at the study hospital has led to an increased prevalence of C. krusei infection. This is the likely reason for the low sensitivity of the test in proven and suspected invasive Candida infections reported here. (C) 2002 Elsevier Science Inc. All rights reserved.

Identificador

http://espace.library.uq.edu.au/view/UQ:61963

Idioma(s)

eng

Publicador

Elsevier Biomedical

Palavras-Chave #Infectious Diseases #Microbiology #Invasive Candidiasis #Cancer #C1 #110801 Medical Bacteriology #110309 Infectious Diseases
Tipo

Journal Article